Detalhe da pesquisa
1.
Combination immunotherapy of PEG-modified preladenant thermosensitive liposomes and PD-1 inhibitor effectively enhances the anti-tumor immune response and therapeutic effects.
Pharm Dev Technol
; 28(6): 501-508, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37191345
2.
Development and characteristics of novel sonosensitive liposomes for vincristine bitartrate.
Drug Deliv
; 26(1): 724-731, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31293182
3.
Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
Drug Deliv
; 26(1): 281-289, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30880491
4.
Redox sensitive PEG controlled octaarginine and targeting peptide co-modified nanostructured lipid carriers for enhanced tumour penetrating and targeting in vitro and in vivo.
Artif Cells Nanomed Biotechnol
; 46(2): 313-322, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28362124
5.
Polyarginine and PEG-AEYLR comodified nanostructured lipid carrier: 10mol% uncleavable PEG-AEYLR showed no shielding effect to polyarginine in vitro while maintaining good tumor targeting in vivo.
Artif Cells Nanomed Biotechnol
; 46(2): 284-292, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28355889
6.
Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma.
Drug Deliv
; 24(1): 1045-1055, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28687044